相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cyclin-dependent kinase 1-mediated phosphorylation of protein kinase N1 promotes anchorage-independent growth and migration
Renya Zeng et al.
CELLULAR SIGNALLING (2020)
Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy
Chao Wang et al.
JOURNAL OF IMMUNOLOGY (2018)
Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy
Steven Coutre et al.
BLOOD (2018)
Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia
Ya Zhang et al.
ONCOGENE (2018)
Genetic Alterations of TRAF Proteins in Human Cancers
Sining Zhu et al.
FRONTIERS IN IMMUNOLOGY (2018)
TRAF1 Signaling in Human Health and Disease
Maria I. Edilova et al.
FRONTIERS IN IMMUNOLOGY (2018)
Modeling the chronic lymphocytic leukemia microenvironment in vitro
Kyle Crassini et al.
LEUKEMIA & LYMPHOMA (2017)
Pathways and mechanisms of venetoclax resistance
Prithviraj Bose et al.
LEUKEMIA & LYMPHOMA (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Impaired lymphocyte trafficking in mice deficient in the kinase activity of PKN1
Rana Mashud et al.
SCIENTIFIC REPORTS (2017)
Microenvironmental agonists generate de novo phenotypic resistance to combined ibrutinib plus venetoclax in CLL and MCL
Kallesh D. Jayappa et al.
BLOOD ADVANCES (2017)
BCR inhibitor failure in CLL: an unmet need
Nitin Jain et al.
BLOOD (2016)
High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells
Sina Oppermann et al.
BLOOD (2016)
Recent advances in therapy of chronic lymphocytic leukaemia
David J. M. Routledge et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
The first MCL-1-selective BH3 mimetics have therapeutic potential for chronic lymphocytic leukemia
Samaher Besbes et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Tofacitinib and analogs as inhibitors of the histone kinase PRK1 (PKN1)
Dmytro Ostrovskyi et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stephan Stilgenbauer et al.
LANCET ONCOLOGY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Targeted therapies in CLL: mechanisms of resistance and strategies for management
Jennifer A. Woyach et al.
BLOOD (2015)
TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation
Hannah Greenfeld et al.
PLOS PATHOGENS (2015)
Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer
Suyoun Chung et al.
Oncotarget (2015)
PDK1 regulates B cell differentiation and homeostasis
Gisele V. Baracho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells
Cordula A. Jilg et al.
ONCOTARGET (2014)
Opposing Roles for TRAF1 in the Alternative versus Classical NF-κB Pathway in T Cells
Ann J. McPherson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Stromal Endothelial Cells Establish a Bidirectional Crosstalk with Chronic Lymphocytic Leukemia Cells through the TNF-Related Factors BAFF, APRIL, and CD40L
Montserrat Cols et al.
JOURNAL OF IMMUNOLOGY (2012)
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Marcus Duehren-von Minden et al.
NATURE (2012)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells
Natalie Grinshtein et al.
CANCER RESEARCH (2011)
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
M. Darding et al.
CELL DEATH AND DIFFERENTIATION (2011)
Crystal Structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 Complexes: Affinity, Specificity, and Regulation
Chao Zheng et al.
MOLECULAR CELL (2010)
PRK1 distribution in normal tissues and carcinomas: overexpression and activation in ovarian serous carcinoma
Mary T. Galgano et al.
HUMAN PATHOLOGY (2009)
Molecular mechanism and function of CD40/CD40L engagement in the immune system
Raul Elgueta et al.
IMMUNOLOGICAL REVIEWS (2009)
TRAF1 is involved in the classical NF-κB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells
Feng Guo et al.
MOLECULAR IMMUNOLOGY (2009)
Negative regulation of constitutive NF-κB and JNK signaling by PKN1-mediated phosphorylation of TRAF1
Tomohisa Kato et al.
GENES TO CELLS (2008)
ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo
Laurent Sabbagh et al.
JOURNAL OF IMMUNOLOGY (2008)
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2008)
Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulationx
Eric Metzger et al.
NATURE CELL BIOLOGY (2008)
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma
James R. Cerhan et al.
BLOOD (2007)
NF-κB2 mutation targets TRAF1 to induce lymphomagenesis
Baochun Zhang et al.
BLOOD (2007)
Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling
Ping Xie et al.
JOURNAL OF IMMUNOLOGY (2006)
Design and synthesis of 7H-pyrrolo[2,3-d]pyrimidines as focal adhesion kinase inhibitors.: Part 1
HS Choi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size
Igor Ruvinsky et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth
AJ Baxendale et al.
ONCOGENE (2005)
TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40
AG Eliopoulos et al.
JOURNAL OF VIROLOGY (2003)
4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1
HW Lee et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling
JR Arron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in Hodgkin-Reed-Sternberg cells
R Horie et al.
ONCOGENE (2002)
TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2
XM Li et al.
NATURE (2002)
TRAF1 is a negative regulator of TNF signaling: Enhanced TNF signaling in TRAF1-deficient mice
EN Tsitsikov et al.
IMMUNITY (2001)
TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies
JM Zapata et al.
JOURNAL OF IMMUNOLOGY (2000)
Phosphorylation of protein kinase N by phosphoinositide-dependent protein kinase-1 mediates insulin signals to the actin cytoskeleton
LQ Dong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Rho GTPase control of protein kinase C-related protein kinase activation by 3-phosphoinositide-dependent protein kinase
P Flynn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
